Thomas Francis Quatieri

Thomas Francis Quatieri

Auto-generated profile, based on publicly available information

Thomas Francis Quatieri

MIT Lincoln Laboratory

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2013
Verified
Conference Paper
Open access
PDF file
JWJohn Williams
John Williams
TQThomas F. Quatieri
Thomas F. Quatieri
BHBrian S. Helfer
Brian S. Helfer
RHRachelle Horwitz
Rachelle Horwitz
BYBea Yu
Bea Yu
DMDaryush D. Mehta
Daryush D. Mehta
In Major Depressive Disorder (MDD), neurophysiologic changes can alter motor control [1, 2] and therefore alter speech production by influencing the characteristics of the vocal source, tract, and prosodics. Clinically, many of these characteristics are associated with psychomotor retardation, where a patient shows sluggishness and motor disorder in vocal articulation, affecting coordination across multiple aspects of production [3, 4]. In this paper, we exploit such effects by selecting features that reflect changes in coordination of vocal tract motion associated with MDD. Specifically, we investigate changes in correlation that occur at different time scales across formant frequencies and also across channels of the delta-mel-cepstrum. Both feature domains provide measures of coordination in vocal tract articulation while reducing effects of a slowly-varying linear channel, which can be introduced by time-varying microphone placements. With these two complementary feature sets, using the AVEC 2013 depression dataset, we design a novel Gaussian mixture model (GMM)-based multivariate regression scheme, referred to as Gaussian Staircase Regression, that provides a root-mean-squared-error (RMSE) of 7.42 and a mean-absolute-error (MAE) of 5.75 on the standard Beck depression rating scale. We are currently exploring

29 May 2020 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
TQThomas F. Quatieri
Thomas F. Quatieri
TTTanya Talkar
Tanya Talkar
JPJeffrey S. Palmer
Jeffrey S. Palmer
Goal: We propose a speech modeling and signal-processing framework to detect and track COVID-19 through asymptomatic and symptomatic stages. Methods: The approach is based on complexity of neuromotor coordination across speech subsystems involved in respiration, phonation and articulation, motivated by the distinct nature of COVID-19 involving lower (i.e., bronchial tubes, diaphragm, lower trachea) versus upper (i.e., laryngeal, pharyngeal, oral and nasal) respiratory tract inflammation [1], as well as by the growing evidence of the virus' neurological manifestations [2]—[5]. Preliminary results: An exploratory study with audio interviews of five subjects provides Cohen's d effect sizes between pre-COVID-19 (pre-exposure) from post-COVID-19 (after positive diagnosis but asymptomatic) using: coordination of respiration (as measured through acoustic waveform amplitude) and laryngeal motion (fundamental frequency and cepstral peak prominence), and coordination of laryngeal and articulatory (formant center frequencies) motion. Conclusions: While there is a strong subject-dependence, the group-level morphology of effect sizes indicates a reduced complexity of subsystem coordination. Validation is needed with larger more controlled datasets and to address confounding influences such as different recording conditions, unbalanced data quantities, and changes in underlying vocal status from pre-to-post time recordings.

11 February 2022 in Perspectives of the Asha Special Interest Groups
Verified
Journal Article
Closed access
VRVikram Ramanarayanan
Vikram Ramanarayanan
ALAdam C. Lammert
Adam C. Lammert
HRHannah Rowe
Hannah Rowe
TQThomas F. Quatieri
Thomas F. Quatieri
JGJordan R. Green
Jordan R. Green
Purpose: Over the past decade, the signal processing and machine learning literature has demonstrated notable advancements in automated speech processing with the use of artificial intelligence for medical assessment and monitoring (e.g., depression, dementia, and Parkinson's disease, among others). Meanwhile, the clinical speech literature has identified several interpretable, theoretically motivated measures that are sensitive to abnormalities in the cognitive, linguistic, affective, motoric, and anatomical domains. Both fields have, thus, independently demonstrated the potential for speech to serve as an informative biomarker for detecting different psychiatric and physiological conditions. However, despite these parallel advancements, automated speech biomarkers have not been integrated into routine clinical practice to date. Conclusions: In this article, we present opportunities and challenges for adoption of speech as a biomarker in clinical practice and research. Toward clinical acceptance and adoption of speech-based digital biomarkers, we argue for the importance of several factors such as robustness, specificity, diversity, and physiological interpretability of speech analytics in clinical applications.

7 August 2020 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
CACatherine P. Adans-Dester
Catherine P. Adans-Dester
SBStacy Bamberg
Stacy Bamberg
FBFrancesco P. Bertacchi
Francesco P. Bertacchi
BCBrian Caulfield
Brian Caulfield
KCKara Chappie
Kara Chappie
PBPaolo Bonato
Paolo Bonato
Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Task Force identified technologies that could be deployed in response to the COVID-19 pandemic and would likely be suitable for future pandemics. Criteria for their evaluation were agreed upon and applied to these systems. Conclusions: mHealth technologies are viable options to monitor COVID-19 patients and be used to predict symptom escalation for earlier intervention. These technologies could also be utilized to monitor individuals who are presumed non-infected and enable prediction of exposure to SARS-CoV-2, thus facilitating the prioritization of diagnostic testing.

16 August 2011 in EURASIP Journal on Advances in Signal Processing
Verified
Journal Article
Open access
PDF file
ATAndrea Carolina Trevino
Andrea Carolina Trevino
TQThomas Francis Quatieri
Thomas Francis Quatieri
NMNicolas Malyska
Nicolas Malyska
Of increasing importance in the civilian and military population is the recognition of major depressive disorder at its earliest stages and intervention before the onset of severe symptoms. Toward the goal of more effective monitoring of depression severity, we introduce vocal biomarkers that are derived automatically from phonologically-based measures of speech rate. To assess our measures, we use a 35-speaker free-response speech database of subjects treated for depression over a 6-week duration. We find that dissecting average measures of speech rate into phone-specific characteristics and, in particular, combined phone-duration measures uncovers stronger relationships between speech rate and depression severity than global measures previously reported for a speech-rate biomarker. Results of this study are supported by correlation of our measures with depression severity and classification of depression state with these vocal measures. Our approach provides a general framework for analyzing individual symptom categories through phonological units, and supports the premise that speaking rate can be an indicator of psychomotor retardation severity.

10 July 2020 in IEEE Access
Verified
Journal Article
Open access
TTTanya Talkar
Tanya Talkar
JWJames R. Williamson
James R. Williamson
DHDaniel J. Hannon
Daniel J. Hannon
HRHrishikesh M. Rao
Hrishikesh M. Rao
SYSophia Yuditskaya
Sophia Yuditskaya
TQThomas F. Quatieri
Thomas F. Quatieri
Autism Spectrum Disorder (ASD) is a developmental disorder characterized by difficulty in communication, which includes a high incidence of speech production errors. We hypothesize that these errors are partly due to underlying deficits in motor coordination and control, which are also manifested in degraded fine motor control of facial expressions and purposeful hand movements. In this pilot study, we computed correlations of acoustic, video, and handwriting time-series derived from five children with ASD and five children with neurotypical development during speech and handwriting tasks. These correlations and eigenvalues derived from the correlations act as a proxy for motor coordination across articulatory, laryngeal, and respiratory speech production systems and for fine motor skills. We utilized features derived from these correlations to discriminate between children with and without ASD. Eigenvalues derived from these correlations highlighted differences in complexity of coordination across speech subsystems and during handwriting, and helped discriminate between the two subject groups. These results suggest differences in coupling within speech production and fine motor skill systems in children with ASD. Our long-term goal is to create a platform assessing motor coordination in children with ASD in order to track progress from speech and motor interventions administered by clinicians.